BioNexus Gene Lab Other Current Liabilities

The latest other current liabilities for BGLC is $740K as of June 2026. That compares with $320K in the prior-year period — up 129.3% year over year. Investors often review this figure alongside BioNexus Gene Lab's historical trend and sector peers before judging valuation or financial health.

Over the past year, BGLC's other current liabilities moved from $320K to $740K — a 129.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioNexus Gene Lab's operating scale or balance-sheet position.

A other current liabilities figure of $740K for BGLC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BGLC's other current liabilities ($740K), review year-over-year change from $320K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.